Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.0404294090451727e-38,inf,inf,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",3.079671050773711e-36,0,0,68
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,4.801423081724786e-20,52.936344969199176,2354.756290722637,"['NDUFB9', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5']",7.106106160952683e-18,0,0,40
3,Nonalcoholic fatty liver disease WP4396,6.582190533832706e-14,13.448938027349433,408.19979601352526,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRFS1', 'CYC1', 'NDUFA7', 'TGFB1', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",6.494427993381604e-12,0,0,36
4,Oxidative phosphorylation WP623,1.5844555020118272e-10,28.077227722772278,633.5797738596265,"['NDUFB9', 'ATP5PF', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFB10', 'NDUFB5', 'NDUFA4', 'ATP6AP2', 'ATP5MC2', 'NDUFB2', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5MF', 'ATP5ME']",1.172497071488752e-08,0,0,22
5,Mitochondrial complex I assembly model OXPHOS system WP4324,5.491910952113961e-08,21.483333333333334,359.14557270333205,"['NDUFB9', 'NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4']",3.251211283651465e-06,0,0,17
6,Mitochondrial CIV Assembly WP4922,8.723597443276898e-08,37.79296875,614.3114432212424,"['COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'COX14', 'COX20']",4.303641405349937e-06,0,0,15
7,Mitochondrial complex III assembly WP4921,4.799839545122736e-05,inf,inf,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.0020296464362233283,0,0,8
8,Amino Acid metabolism WP3925,0.00016716549671301636,inf,inf,"['LDHA', 'PKM', 'GOT1', 'MDH2', 'GSS', 'ODC1', 'SRM']",0.005497887447450315,0,0,7
9,Glycolysis and Gluconeogenesis WP534,0.00016716549671301636,inf,inf,"['LDHA', 'PKM', 'GOT1', 'MDH2', 'PGAM1', 'ALDOC', 'PFKM']",0.005497887447450315,0,0,7
10,Cellular Proteostasis WP4918,0.024259852067755185,inf,inf,"['VBP1', 'PFDN5', 'PFDN6']",0.5462772565095841,0,0,3
11,Computational Model of Aerobic Glycolysis WP4629,0.024259852067755185,inf,inf,"['LDHA', 'PKM', 'PFKM']",0.5462772565095841,0,0,3
12,Glycolysis in senescence WP5049,0.024259852067755185,inf,inf,"['LDHA', 'PKM', 'ALDOC']",0.5462772565095841,0,0,3
13,Acute viral myocarditis WP4298,0.0245642068099432,6.173371647509579,22.881385346653307,"['ENDOG', 'TGFB1', 'CYCS', 'BAX', 'EIF4G2']",0.5462772565095841,0,0,5
14,VEGFA-VEGFR2 Signaling Pathway WP3888,0.02583743780788574,1.831155115511551,6.694576315008056,"['HSP90AA1', 'SET', 'SSR4', 'TRPC3', 'PRKCD', 'RPS6', 'RPL13A', 'RPL10A', 'RPL7', 'SCUBE2', 'LDHA', 'RPL18A', 'TMSB4X', 'RPLP2', 'CYCS', 'RPL27', 'PRKD1', 'RPL26', 'ATP6V1E1', 'CCT7', 'EIF3D', 'EIF4G2']",0.5462772565095841,0,0,22
15,Corticotropin-releasing hormone signaling pathway WP2355,0.062409433910297296,4.92925430210325,13.673942839808758,"['HSP90AA1', 'TGFB1', 'PRKCD', 'CRH']",0.7303613962131801,0,0,4
16,Metabolic reprogramming in colon cancer WP4290,0.062409433910297296,4.92925430210325,13.673942839808758,"['LDHA', 'PKM', 'MDH2', 'PGAM1']",0.7303613962131801,0,0,4
17,Nanomaterial induced apoptosis WP2507,0.0760277534262657,7.385496183206107,19.029889173760232,"['ENDOG', 'BAX', 'CYCS']",0.7303613962131801,0,0,3
18,Nucleotide metabolism WP404,0.0760277534262657,7.385496183206107,19.029889173760232,"['NME2', 'OAZ1', 'SRM']",0.7303613962131801,0,0,3
19,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.0760277534262657,7.385496183206107,19.029889173760232,"['NDUFA13', 'HSP90AA1', 'AAMP']",0.7303613962131801,0,0,3
20,Selenium Micronutrient Network WP15,0.07861822352512944,2.4692307692307693,6.279628564159652,"['SELENOM', 'GPX4', 'SELENOS', 'SELENOW', 'SELENOK', 'SEPHS2', 'SELENOH']",0.7303613962131801,0,0,7
21,CAMKK2  Pathway WP4874,0.08391629124789343,inf,inf,"['FIS1', 'MAP1LC3A']",0.7303613962131801,0,0,2
22,Type II diabetes mellitus WP1584,0.08391629124789343,inf,inf,"['SURF1', 'PRKCD']",0.7303613962131801,0,0,2
23,Urea cycle and associated pathways WP4595,0.08391629124789343,inf,inf,"['GOT1', 'MDH2']",0.7303613962131801,0,0,2
24,Urea cycle and metabolism of amino groups WP497,0.08391629124789343,inf,inf,"['ODC1', 'SRM']",0.7303613962131801,0,0,2
25,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.08391629124789343,inf,inf,"['TGFB1', 'VIP']",0.7303613962131801,0,0,2
26,Cori Cycle WP1946,0.08391629124789343,inf,inf,"['LDHA', 'PGAM1']",0.7303613962131801,0,0,2
27,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.08391629124789343,inf,inf,"['H3F3B', 'H2AFZ']",0.7303613962131801,0,0,2
28,Gastric acid production WP2596,0.08391629124789343,inf,inf,"['CCK', 'VIP']",0.7303613962131801,0,0,2
29,Glutathione metabolism WP100,0.08391629124789343,inf,inf,"['GPX4', 'GSS']",0.7303613962131801,0,0,2
30,Histone Modifications WP2369,0.08391629124789343,inf,inf,"['SET', 'H3F3B']",0.7303613962131801,0,0,2
31,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.08391629124789343,inf,inf,"['SFRP1', 'TGFB1']",0.7303613962131801,0,0,2
32,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.08391629124789343,inf,inf,"['GOT1', 'MDH2']",0.7303613962131801,0,0,2
33,NO/cGMP/PKG mediated Neuroprotection WP4008,0.08391629124789343,inf,inf,"['PDE3A', 'CYCS']",0.7303613962131801,0,0,2
34,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.08391629124789343,inf,inf,"['TGFB1', 'BAX']",0.7303613962131801,0,0,2
35,Proteasome Degradation WP183,0.0863603002279098,3.081896551724138,7.548264852428884,"['PSMB6', 'PSMC5', 'H2AFZ', 'HLA-B', 'PSMB10']",0.7303613962131801,0,0,5
36,Pathways in clear cell renal cell carcinoma WP4018,0.13283870870273376,2.4636015325670497,4.973074348155069,"['LDHA', 'PKM', 'TGFB1', 'ALDOC', 'PFKM']",0.9140882723112068,0,0,5
37,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.14965583458803608,3.689885496183206,7.008631450629282,"['LDHA', 'PKM', 'BAX']",0.9140882723112068,0,0,3
38,Pregnane X receptor pathway WP2876,0.14965583458803608,3.689885496183206,7.008631450629282,"['HSP90AA1', 'PSMC5', 'CYP3A5']",0.9140882723112068,0,0,3
39,Rett syndrome causing genes WP4312,0.14965583458803608,3.689885496183206,7.008631450629282,"['IMPDH2', 'HAP1', 'GABRD']",0.9140882723112068,0,0,3
40,Aryl Hydrocarbon Receptor Pathway WP2873,0.17567356958371913,2.4608030592734225,4.27965082451803,"['HSP90AA1', 'TGFB1', 'AIP', 'BAX']",0.9140882723112068,0,0,4
41,Modulators of TCR signaling and T cell activation WP5072,0.17567356958371913,2.4608030592734225,4.27965082451803,"['FIBP', 'NDUFB10', 'ELOB', 'RNF7']",0.9140882723112068,0,0,4
42,Ferroptosis WP4313,0.18793758364432614,2.0514048531289912,3.4292214312293043,"['MAP1LC3A', 'GPX4', 'GSS', 'SAT2', 'FTL']",0.9140882723112068,0,0,5
43,DNA Repair Pathways Full Network WP4946,0.19382133890886083,1.8469289827255277,3.030475201852092,"['FANCI', 'POLE4', 'DCLRE1C', 'NEIL2', 'CENPX', 'APEX1']",0.9140882723112068,0,0,6
44,Pyrimidine metabolism WP4022,0.19382133890886083,1.8469289827255277,3.030475201852092,"['POLE4', 'NME2', 'NME3', 'POLR2I', 'POLR2K', 'POLR2L']",0.9140882723112068,0,0,6
45,ACE Inhibitor Pathway WP554,0.2032291741150204,4.914285714285715,7.8305260580411575,"['TGFB1', 'ATP6AP2']",0.9140882723112068,0,0,2
46,Amyotrophic lateral sclerosis (ALS) WP2447,0.2032291741150204,4.914285714285715,7.8305260580411575,"['TOMM40', 'BAX']",0.9140882723112068,0,0,2
47,Type II interferon signaling (IFNG) WP619,0.2032291741150204,4.914285714285715,7.8305260580411575,"['PRKCD', 'HLA-B']",0.9140882723112068,0,0,2
48,Cysteine and methionine catabolism WP4504,0.2032291741150204,4.914285714285715,7.8305260580411575,"['GOT1', 'GSS']",0.9140882723112068,0,0,2
49,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.2032291741150204,4.914285714285715,7.8305260580411575,"['MAP1LC3A', 'FTL']",0.9140882723112068,0,0,2
50,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.2032291741150204,4.914285714285715,7.8305260580411575,"['EIF3I', 'EIF3D']",0.9140882723112068,0,0,2
51,Oxidation by Cytochrome P450 WP43,0.2032291741150204,4.914285714285715,7.8305260580411575,"['CYB5R1', 'CYP3A5']",0.9140882723112068,0,0,2
52,16p11.2 proximal deletion syndrome WP4949,0.23690224153208353,2.4580152671755724,3.5398067275494505,"['ASPHD1', 'SEZ6L2', 'CCT7']",0.9140882723112068,0,0,3
53,Base Excision Repair WP4752,0.23690224153208353,2.4580152671755724,3.5398067275494505,"['POLE4', 'NEIL2', 'APEX1']",0.9140882723112068,0,0,3
54,Differentiation Pathway WP2848,0.23690224153208353,2.4580152671755724,3.5398067275494505,"['TGFB1', 'KIT', 'FGF1']",0.9140882723112068,0,0,3
55,DNA IR-double strand breaks and cellular response via ATM WP3959,0.23690224153208353,2.4580152671755724,3.5398067275494505,"['DCLRE1C', 'KAT5', 'BAX']",0.9140882723112068,0,0,3
56,GABA receptor Signaling WP4159,0.23690224153208353,2.4580152671755724,3.5398067275494505,"['GABBR1', 'SLC32A1', 'GABRD']",0.9140882723112068,0,0,3
57,Ciliary landscape WP4352,0.2456368330527212,1.5664335664335665,2.1991178418316624,"['VPS4A', 'CD2BP2', 'COPS7A', 'MYL6B', 'COX6C', 'DCAF11', 'LSM4']",0.9140882723112068,0,0,7
58,Endoderm differentiation WP2853,0.24712418708340494,1.967112810707457,2.7497567465730888,"['DUSP4', 'SFRP1', 'TGFB1', 'TCEAL2']",0.9140882723112068,0,0,4
59,Apoptosis Modulation and Signaling WP1772,0.24950947144363234,1.7569786535303777,2.439140379326908,"['HRK', 'ENDOG', 'CYCS', 'BAX', 'PRKD1']",0.9140882723112068,0,0,5
60,Gastrin signaling pathway WP4659,0.24950947144363234,1.7569786535303777,2.439140379326908,"['KAT5', 'RPS6', 'PRKCD', 'KIT', 'PRKD1']",0.9140882723112068,0,0,5
61,15q11.2 copy number variation syndrome WP4940,0.289878775936539,inf,inf,['TUBGCP4'],0.9140882723112068,0,0,1
62,Selective expression of chemokine receptors during T-cell polarization WP4494,0.289878775936539,inf,inf,['TGFB1'],0.9140882723112068,0,0,1
63,16p11.2 distal deletion syndrome WP4950,0.289878775936539,inf,inf,['CD81'],0.9140882723112068,0,0,1
64,Apoptosis Modulation by HSP70 WP384,0.289878775936539,inf,inf,['CYCS'],0.9140882723112068,0,0,1
65,Tamoxifen metabolism WP691,0.289878775936539,inf,inf,['CYP3A5'],0.9140882723112068,0,0,1
66,TCA cycle in senescence WP5050,0.289878775936539,inf,inf,['GOT1'],0.9140882723112068,0,0,1
67,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.289878775936539,inf,inf,['TGFB1'],0.9140882723112068,0,0,1
68,Biomarkers for urea cycle disorders WP4583,0.289878775936539,inf,inf,['GOT1'],0.9140882723112068,0,0,1
69,Thiamine metabolic pathways WP4297,0.289878775936539,inf,inf,['BCKDK'],0.9140882723112068,0,0,1
70,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.289878775936539,inf,inf,['RPS6'],0.9140882723112068,0,0,1
71,Canonical and non-canonical TGF-B signaling WP3874,0.289878775936539,inf,inf,['TGFB1'],0.9140882723112068,0,0,1
72,"Cerebral organic acidurias, including diseases WP4519",0.289878775936539,inf,inf,['MDH2'],0.9140882723112068,0,0,1
73,Ebstein-Barr virus LMP1 signaling WP262,0.289878775936539,inf,inf,['HSP90AA1'],0.9140882723112068,0,0,1
74,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.289878775936539,inf,inf,['H3F3B'],0.9140882723112068,0,0,1
75,EV release from cardiac cells and their functional effects WP3297,0.289878775936539,inf,inf,['RGS16'],0.9140882723112068,0,0,1
76,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.289878775936539,inf,inf,['GSS'],0.9140882723112068,0,0,1
77,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.289878775936539,inf,inf,['GABBR1'],0.9140882723112068,0,0,1
78,HIF1A and PPARG regulation of glycolysis WP2456,0.289878775936539,inf,inf,['LDHA'],0.9140882723112068,0,0,1
79,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.289878775936539,inf,inf,['ELOB'],0.9140882723112068,0,0,1
80,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.289878775936539,inf,inf,['MAP1LC3A'],0.9140882723112068,0,0,1
81,Insulin signaling in adipocytes (diabetic condition) WP3635,0.289878775936539,inf,inf,['RPS6'],0.9140882723112068,0,0,1
82,Insulin signaling in adipocytes (normal condition) WP3634,0.289878775936539,inf,inf,['RPS6'],0.9140882723112068,0,0,1
83,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.289878775936539,inf,inf,['TGFB1'],0.9140882723112068,0,0,1
84,Irinotecan pathway WP229,0.289878775936539,inf,inf,['CYP3A5'],0.9140882723112068,0,0,1
85,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.289878775936539,inf,inf,['GABRD'],0.9140882723112068,0,0,1
86,Mitochondrial fatty acid synthesis pathway WP4317,0.289878775936539,inf,inf,['HSD17B12'],0.9140882723112068,0,0,1
87,Nanoparticle triggered autophagic cell death WP2509,0.289878775936539,inf,inf,['MAP1LC3A'],0.9140882723112068,0,0,1
88,Nanoparticle triggered regulated necrosis WP2513,0.289878775936539,inf,inf,['FTL'],0.9140882723112068,0,0,1
89,Non-homologous end joining WP438,0.289878775936539,inf,inf,['DCLRE1C'],0.9140882723112068,0,0,1
90,Peroxiredoxin 2 induced ovarian failure WP4873,0.289878775936539,inf,inf,['BAX'],0.9140882723112068,0,0,1
91,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.289878775936539,inf,inf,['LDHA'],0.9140882723112068,0,0,1
92,Platelet-mediated interactions with vascular and circulating cells WP4462,0.289878775936539,inf,inf,['TGFB1'],0.9140882723112068,0,0,1
93,IL-18 signaling pathway WP4754,0.308248358131454,1.2892211148025101,1.5172191771212642,"['TOMM40', 'USP5', 'CD81', 'TMSB4X', 'RGS16', 'SYT10', 'PRKCD', 'COX17', 'CYCS', 'BAX', 'NDUFC1']",0.9140882723112068,0,0,11
94,mRNA Processing WP411,0.315172525001387,1.5361590038314177,1.773703092210794,"['SF3B5', 'LSM7', 'SF3A1', 'CD2BP2', 'SRSF9']",0.9140882723112068,0,0,5
95,Exercise-induced Circadian Regulation WP410,0.32331449347635827,1.6379859783301467,1.8494987235212141,"['DAZAP2', 'SUMO1', 'GSTP1', 'EIF4G2']",0.9140882723112068,0,0,4
96,Proximal tubule transport WP4917,0.32331449347635827,1.6379859783301467,1.8494987235212141,"['ATP6V1G1', 'ATP6V1E1', 'ATP6V1D', 'ATP6V1F']",0.9140882723112068,0,0,4
97,Synaptic Vesicle Pathway WP2267,0.32992657443139783,1.8420801526717556,2.0426553282528914,"['SLC32A1', 'PARK7', 'CPLX3']",0.9140882723112068,0,0,3
98,Translation Factors WP107,0.32992657443139783,1.8420801526717556,2.0426553282528914,"['EEF1B2', 'EIF3I', 'EIF3D']",0.9140882723112068,0,0,3
99,Eukaryotic Transcription Initiation WP405,0.32992657443139783,1.8420801526717556,2.0426553282528914,"['TAF13', 'POLR2I', 'POLR2K']",0.9140882723112068,0,0,3
100,Sleep regulation WP3591,0.33043055789628084,2.455238095238095,2.718829397995947,"['CRH', 'HCRTR2']",0.9140882723112068,0,0,2
101,ATM Signaling Network in Development and Disease  WP3878,0.33043055789628084,2.455238095238095,2.718829397995947,"['DCLRE1C', 'KAT5']",0.9140882723112068,0,0,2
102,Cardiac Hypertrophic Response WP2795,0.33043055789628084,2.455238095238095,2.718829397995947,"['TGFB1', 'PRKD1']",0.9140882723112068,0,0,2
103,Type 2 papillary renal cell carcinoma WP4241,0.33043055789628084,2.455238095238095,2.718829397995947,"['TGFB1', 'ELOB']",0.9140882723112068,0,0,2
104,Constitutive Androstane Receptor Pathway WP2875,0.33043055789628084,2.455238095238095,2.718829397995947,"['HSP90AA1', 'CYP3A5']",0.9140882723112068,0,0,2
105,Cytosolic DNA-sensing pathway WP4655,0.33043055789628084,2.455238095238095,2.718829397995947,"['POLR2K', 'POLR2L']",0.9140882723112068,0,0,2
106,Methionine De Novo and Salvage Pathway WP3580,0.33043055789628084,2.455238095238095,2.718829397995947,"['ODC1', 'SRM']",0.9140882723112068,0,0,2
107,Neovascularisation processes WP4331,0.33043055789628084,2.455238095238095,2.718829397995947,"['TGFB1', 'KIT']",0.9140882723112068,0,0,2
108,Hepatitis B infection WP4666,0.4006727031566493,1.402895383774925,1.2831026892489554,"['TGFB1', 'ATP6AP1', 'CYCS', 'BAX']",0.9705683052108761,0,0,4
109,Metapathway biotransformation Phase I and II WP702,0.4006727031566493,1.402895383774925,1.2831026892489554,"['GPX4', 'GSTP1', 'GSS', 'CYP3A5']",0.9705683052108761,0,0,4
110,Apoptosis WP254,0.42247834238994353,1.4725190839694657,1.2687476141576175,"['HRK', 'CYCS', 'BAX']",0.9705683052108761,0,0,3
111,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.42247834238994353,1.4725190839694657,1.2687476141576175,"['TGFB1', 'CYCS', 'BAX']",0.9705683052108761,0,0,3
112,miRNA regulation of DNA damage response WP1530,0.42247834238994353,1.4725190839694657,1.2687476141576175,"['CCNG1', 'CYCS', 'BAX']",0.9705683052108761,0,0,3
113,AGE/RAGE pathway WP2324,0.450946980202595,1.6355555555555557,1.3025654513125424,"['PRKCD', 'CYCS']",0.9705683052108761,0,0,2
114,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.450946980202595,1.6355555555555557,1.3025654513125424,"['SFRP1', 'SST']",0.9705683052108761,0,0,2
115,TNF-alpha signaling pathway WP231,0.450946980202595,1.6355555555555557,1.3025654513125424,"['HSP90AA1', 'BAX']",0.9705683052108761,0,0,2
116,TP53 network WP1742,0.450946980202595,1.6355555555555557,1.3025654513125424,"['SUMO1', 'BAX']",0.9705683052108761,0,0,2
117,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.450946980202595,1.6355555555555557,1.3025654513125424,"['PRKCD', 'RPS6']",0.9705683052108761,0,0,2
118,Glycosylation and related congenital defects WP4521,0.450946980202595,1.6355555555555557,1.3025654513125424,"['DPM2', 'DPM3']",0.9705683052108761,0,0,2
119,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.450946980202595,1.6355555555555557,1.3025654513125424,"['LDHA', 'RPS6']",0.9705683052108761,0,0,2
120,Interleukin-11 Signaling Pathway WP2332,0.450946980202595,1.6355555555555557,1.3025654513125424,"['TGFB1', 'RPS6']",0.9705683052108761,0,0,2
121,Kit receptor signaling pathway WP304,0.450946980202595,1.6355555555555557,1.3025654513125424,"['RPS6', 'KIT']",0.9705683052108761,0,0,2
122,Parkinson's disease pathway WP2371,0.450946980202595,1.6355555555555557,1.3025654513125424,"['CYCS', 'PARK7']",0.9705683052108761,0,0,2
123,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.450946980202595,1.6355555555555557,1.3025654513125424,"['HSP90AA1', 'BAX']",0.9705683052108761,0,0,2
124,Spinal Cord Injury WP2431,0.476254284906932,1.2265774378585086,0.9098792590635735,"['TGFB1', 'APEX1', 'CCNG1', 'OMG']",0.9705683052108761,0,0,4
125,Serotonin and anxiety WP3947,0.49584103863547957,2.452471482889734,1.7204084760786895,['CRH'],0.9705683052108761,0,0,1
126,Serotonin and anxiety-related events WP3944,0.49584103863547957,2.452471482889734,1.7204084760786895,['CRH'],0.9705683052108761,0,0,1
127,Signal transduction through IL1R WP4496,0.49584103863547957,2.452471482889734,1.7204084760786895,['TGFB1'],0.9705683052108761,0,0,1
128,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.49584103863547957,2.452471482889734,1.7204084760786895,['GSTP1'],0.9705683052108761,0,0,1
129,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.49584103863547957,2.452471482889734,1.7204084760786895,['MDH2'],0.9705683052108761,0,0,1
130,Trans-sulfuration and one-carbon metabolism WP2525,0.49584103863547957,2.452471482889734,1.7204084760786895,['GSS'],0.9705683052108761,0,0,1
131,Trans-sulfuration pathway WP2333,0.49584103863547957,2.452471482889734,1.7204084760786895,['GOT1'],0.9705683052108761,0,0,1
132,Transcriptional cascade regulating adipogenesis WP4211,0.49584103863547957,2.452471482889734,1.7204084760786895,['DDIT3'],0.9705683052108761,0,0,1
133,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.49584103863547957,2.452471482889734,1.7204084760786895,['CCK'],0.9705683052108761,0,0,1
134,Cytokines and Inflammatory Response WP530,0.49584103863547957,2.452471482889734,1.7204084760786895,['TGFB1'],0.9705683052108761,0,0,1
135,Dopaminergic Neurogenesis WP2855,0.49584103863547957,2.452471482889734,1.7204084760786895,['TGFB1'],0.9705683052108761,0,0,1
136,Dual hijack model of Vif in HIV infection WP3300,0.49584103863547957,2.452471482889734,1.7204084760786895,['ELOB'],0.9705683052108761,0,0,1
137,Heart Development WP1591,0.49584103863547957,2.452471482889734,1.7204084760786895,['VEGFB'],0.9705683052108761,0,0,1
138,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.49584103863547957,2.452471482889734,1.7204084760786895,['BAX'],0.9705683052108761,0,0,1
139,Interferon type I signaling pathways WP585,0.49584103863547957,2.452471482889734,1.7204084760786895,['RPS6'],0.9705683052108761,0,0,1
140,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.49584103863547957,2.452471482889734,1.7204084760786895,['BAX'],0.9705683052108761,0,0,1
141,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.49584103863547957,2.452471482889734,1.7204084760786895,['VEGFB'],0.9705683052108761,0,0,1
142,miRNA regulation of p53 pathway in prostate cancer WP3982,0.49584103863547957,2.452471482889734,1.7204084760786895,['BAX'],0.9705683052108761,0,0,1
143,MTHFR deficiency WP4288,0.49584103863547957,2.452471482889734,1.7204084760786895,['CYCS'],0.9705683052108761,0,0,1
144,Osteoclast Signaling WP12,0.49584103863547957,2.452471482889734,1.7204084760786895,['ATP6V1G1'],0.9705683052108761,0,0,1
145,Overview of nanoparticle effects WP3287,0.49584103863547957,2.452471482889734,1.7204084760786895,['BAX'],0.9705683052108761,0,0,1
146,PKC-gamma calcium signaling pathway in ataxia WP4760,0.49584103863547957,2.452471482889734,1.7204084760786895,['TRPC3'],0.9705683052108761,0,0,1
147,Purinergic signaling WP4900,0.49584103863547957,2.452471482889734,1.7204084760786895,['P2RY14'],0.9705683052108761,0,0,1
148,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.49584103863547957,2.452471482889734,1.7204084760786895,['ANAPC11'],0.9705683052108761,0,0,1
149,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.49584103863547957,2.452471482889734,1.7204084760786895,['TGFB1'],0.9705683052108761,0,0,1
150,SARS-CoV-2 mitochondrial interactions WP5038,0.49584103863547957,2.452471482889734,1.7204084760786895,['NDUFB9'],0.9705683052108761,0,0,1
151,Allograft Rejection WP2328,0.5101553728880764,1.2261450381679388,0.8252445914283919,"['TGFB1', 'COL5A1', 'HLA-B']",0.9705683052108761,0,0,3
152,Pancreatic adenocarcinoma pathway WP4263,0.5101553728880764,1.2261450381679388,0.8252445914283919,"['TGFB1', 'PRKCD', 'BAX']",0.9705683052108761,0,0,3
153,MAPK Signaling Pathway WP382,0.5146467972101658,1.114594218042494,0.7403964547741754,"['DUSP4', 'TGFB1', 'DDIT3', 'PRKCD', 'FGF1']",0.9705683052108761,0,0,5
154,Androgen receptor signaling pathway WP138,0.5478461364564784,1.089441257701296,0.6555830475240618,"['SUMO1', 'KAT5', 'STUB1', 'PARK7']",0.9705683052108761,0,0,4
155,Alzheimer's disease WP2059,0.5579692766120097,1.2257142857142858,0.715144688975185,"['ATP5MD', 'CYCS']",0.9705683052108761,0,0,2
156,Aryl Hydrocarbon Receptor Netpath WP2586,0.5579692766120097,1.2257142857142858,0.715144688975185,"['HSP90AA1', 'AIP']",0.9705683052108761,0,0,2
157,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.5579692766120097,1.2257142857142858,0.715144688975185,"['APEX1', 'RPS6']",0.9705683052108761,0,0,2
158,Complement system WP2806,0.5579692766120097,1.2257142857142858,0.715144688975185,"['RPS19', 'CD59']",0.9705683052108761,0,0,2
159,Copper homeostasis WP3286,0.5579692766120097,1.2257142857142858,0.715144688975185,"['COX17', 'ATOX1']",0.9705683052108761,0,0,2
160,Genotoxicity pathway WP4286,0.5579692766120097,1.2257142857142858,0.715144688975185,"['RPS27', 'PHLDA3']",0.9705683052108761,0,0,2
161,IL-6 signaling pathway WP364,0.5579692766120097,1.2257142857142858,0.715144688975185,"['PRKCD', 'VIP']",0.9705683052108761,0,0,2
162,Lung fibrosis WP3624,0.5579692766120097,1.2257142857142858,0.715144688975185,"['TGFB1', 'FGF1']",0.9705683052108761,0,0,2
163,One-carbon metabolism and related pathways WP3940,0.5579692766120097,1.2257142857142858,0.715144688975185,"['GPX4', 'GSS']",0.9705683052108761,0,0,2
164,p53 transcriptional gene network WP4963,0.5579692766120097,1.2257142857142858,0.715144688975185,"['CCNG1', 'BAX']",0.9705683052108761,0,0,2
165,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.5579692766120097,1.2257142857142858,0.715144688975185,"['BAX', 'ANGPTL1']",0.9705683052108761,0,0,2
166,7q11.23 copy number variation syndrome WP4932,0.5902299795624787,1.0501635768811342,0.5536914180418246,"['ATP5MC2', 'ATP5F1E', 'ATP5MC1']",0.9705683052108761,0,0,3
167,Alanine and aspartate metabolism WP106,0.6421468103784275,1.2252851711026616,0.5427257611306502,['GOT1'],0.9705683052108761,0,0,1
168,Alpha 6 Beta 4 signaling pathway WP244,0.6421468103784275,1.2252851711026616,0.5427257611306502,['PRKCD'],0.9705683052108761,0,0,1
169,Cell migration and invasion through p75NTR WP4561,0.6421468103784275,1.2252851711026616,0.5427257611306502,['EFNB3'],0.9705683052108761,0,0,1
170,Vitamin D-sensitive calcium signaling in depression WP4698,0.6421468103784275,1.2252851711026616,0.5427257611306502,['GPX4'],0.9705683052108761,0,0,1
171,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.6421468103784275,1.2252851711026616,0.5427257611306502,['CD81'],0.9705683052108761,0,0,1
172,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.6421468103784275,1.2252851711026616,0.5427257611306502,['RPS6'],0.9705683052108761,0,0,1
173,Galanin receptor pathway WP4970,0.6421468103784275,1.2252851711026616,0.5427257611306502,['PRKCD'],0.9705683052108761,0,0,1
174,Gastric Cancer Network 2 WP2363,0.6421468103784275,1.2252851711026616,0.5427257611306502,['FANCI'],0.9705683052108761,0,0,1
175,Genes targeted by miRNAs in adipocytes WP1992,0.6421468103784275,1.2252851711026616,0.5427257611306502,['TMSB4X'],0.9705683052108761,0,0,1
176,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.6421468103784275,1.2252851711026616,0.5427257611306502,['FGF1'],0.9705683052108761,0,0,1
177,Hepatitis C and Hepatocellular Carcinoma WP3646,0.6421468103784275,1.2252851711026616,0.5427257611306502,['TGFB1'],0.9705683052108761,0,0,1
178,IL-3 signaling pathway WP286,0.6421468103784275,1.2252851711026616,0.5427257611306502,['TGFB1'],0.9705683052108761,0,0,1
179,IL-5 signaling pathway WP127,0.6421468103784275,1.2252851711026616,0.5427257611306502,['RPS6'],0.9705683052108761,0,0,1
180,Joubert Syndrome WP4656,0.6421468103784275,1.2252851711026616,0.5427257611306502,['KAT5'],0.9705683052108761,0,0,1
181,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.6421468103784275,1.2252851711026616,0.5427257611306502,['PRKCD'],0.9705683052108761,0,0,1
182,Matrix Metalloproteinases WP129,0.6421468103784275,1.2252851711026616,0.5427257611306502,['MMP16'],0.9705683052108761,0,0,1
183,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.6421468103784275,1.2252851711026616,0.5427257611306502,['B3GALT2'],0.9705683052108761,0,0,1
184,Neural Crest Cell Migration during Development WP4564,0.6421468103784275,1.2252851711026616,0.5427257611306502,['EPHB3'],0.9705683052108761,0,0,1
185,Neural Crest Cell Migration in Cancer WP4565,0.6421468103784275,1.2252851711026616,0.5427257611306502,['EPHB3'],0.9705683052108761,0,0,1
186,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.6421468103784275,1.2252851711026616,0.5427257611306502,['GSTP1'],0.9705683052108761,0,0,1
187,Pre-implantation embryo WP3527,0.6421468103784275,1.2252851711026616,0.5427257611306502,['DDIT3'],0.9705683052108761,0,0,1
188,Prolactin Signaling Pathway WP2037,0.6421468103784275,1.2252851711026616,0.5427257611306502,['RPS6'],0.9705683052108761,0,0,1
189,DNA damage response WP707,0.6491862765463385,0.9798095238095238,0.4233125784443431,"['CYCS', 'BAX']",0.9705683052108761,0,0,2
190,Leptin signaling pathway WP2034,0.6491862765463385,0.9798095238095238,0.4233125784443431,"['RPS6', 'BAX']",0.9705683052108761,0,0,2
191,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.6491862765463385,0.9798095238095238,0.4233125784443431,"['IFI27L2', 'PRKCD']",0.9705683052108761,0,0,2
192,TGF-beta Signaling Pathway WP366,0.6613138958683066,0.9181774809160306,0.3796908775896269,"['TGFB1', 'PARD6A', 'SUMO1']",0.9705683052108761,0,0,3
193,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.6613138958683066,0.9181774809160306,0.3796908775896269,"['RPS6', 'PDGFC', 'BAX']",0.9705683052108761,0,0,3
194,Osteoblast differentiation WP4787,0.6613138958683066,0.9181774809160306,0.3796908775896269,"['PRKCD', 'PRKD1', 'FGF1']",0.9705683052108761,0,0,3
195,Calcium Regulation in the Cardiac Cell WP536,0.6736886608290164,0.8899704501998957,0.35152693829383597,"['RGS16', 'PRKCD', 'ATP1B2', 'PRKD1']",0.9705683052108761,0,0,4
196,Myometrial relaxation and contraction pathways WP289,0.6736886608290164,0.8899704501998957,0.35152693829383597,"['RGS16', 'PRKCD', 'CRH', 'PRKD1']",0.9705683052108761,0,0,4
197,NRF2 pathway WP2884,0.6855229391932015,0.8737000547345375,0.32988582780979425,"['HSP90AA1', 'TGFB1', 'GSTP1', 'SLC39A7', 'FTL']",0.9705683052108761,0,0,5
198,22q11.2 copy number variation syndrome WP4657,0.724755501874838,0.8158730158730159,0.262646591708682,"['RANBP1', 'MRPL40']",0.9705683052108761,0,0,2
199,B Cell Receptor Signaling Pathway WP23,0.724755501874838,0.8158730158730159,0.262646591708682,"['CD81', 'PRKCD']",0.9705683052108761,0,0,2
200,Cardiac Progenitor Differentiation WP2406,0.724755501874838,0.8158730158730159,0.262646591708682,"['TGFB1', 'KIT']",0.9705683052108761,0,0,2
201,Wnt signaling pathway and pluripotency WP399,0.724755501874838,0.8158730158730159,0.262646591708682,"['PRKCD', 'PRKD1']",0.9705683052108761,0,0,2
202,Endometrial cancer WP4155,0.724755501874838,0.8158730158730159,0.262646591708682,"['BAX', 'FGF1']",0.9705683052108761,0,0,2
203,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.724755501874838,0.8158730158730159,0.262646591708682,"['MAP1LC3A', 'DDIT3']",0.9705683052108761,0,0,2
204,MECP2 and Associated Rett Syndrome WP3584,0.724755501874838,0.8158730158730159,0.262646591708682,"['SST', 'RPS6']",0.9705683052108761,0,0,2
205,Non-small cell lung cancer WP4255,0.724755501874838,0.8158730158730159,0.262646591708682,"['CYCS', 'BAX']",0.9705683052108761,0,0,2
206,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.7460520881967414,0.8162230671736375,0.23912059377052985,['TGFB1'],0.9705683052108761,0,0,1
207,Target Of Rapamycin (TOR) Signaling WP1471,0.7460520881967414,0.8162230671736375,0.23912059377052985,['RRAGA'],0.9705683052108761,0,0,1
208,BDNF-TrkB Signaling WP3676,0.7460520881967414,0.8162230671736375,0.23912059377052985,['TRPC3'],0.9705683052108761,0,0,1
209,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.7460520881967414,0.8162230671736375,0.23912059377052985,['TGFB1'],0.9705683052108761,0,0,1
210,BMP Signaling Pathway in Eyelid Development WP3927,0.7460520881967414,0.8162230671736375,0.23912059377052985,['SFRP1'],0.9705683052108761,0,0,1
211,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.7460520881967414,0.8162230671736375,0.23912059377052985,['TGFB1'],0.9705683052108761,0,0,1
212,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.7460520881967414,0.8162230671736375,0.23912059377052985,['MAP1LC3A'],0.9705683052108761,0,0,1
213,Fas ligand pathway and stress induction of heat shock proteins WP314,0.7460520881967414,0.8162230671736375,0.23912059377052985,['CYCS'],0.9705683052108761,0,0,1
214,Glycogen Synthesis and Degradation WP500,0.7460520881967414,0.8162230671736375,0.23912059377052985,['PHKG1'],0.9705683052108761,0,0,1
215,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7460520881967414,0.8162230671736375,0.23912059377052985,['DDIT3'],0.9705683052108761,0,0,1
216,IL-2 signaling pathway WP49,0.7460520881967414,0.8162230671736375,0.23912059377052985,['RPS6'],0.9705683052108761,0,0,1
217,Integrated Cancer Pathway WP1971,0.7460520881967414,0.8162230671736375,0.23912059377052985,['BAX'],0.9705683052108761,0,0,1
218,Mesodermal commitment pathway WP2857,0.7460520881967414,0.8162230671736375,0.23912059377052985,['RPL38'],0.9705683052108761,0,0,1
219,miR-509-3p alteration of YAP1/ECM axis WP3967,0.7460520881967414,0.8162230671736375,0.23912059377052985,['COL5A1'],0.9705683052108761,0,0,1
220,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.7460520881967414,0.8162230671736375,0.23912059377052985,['OMG'],0.9705683052108761,0,0,1
221,Ovarian infertility WP34,0.7460520881967414,0.8162230671736375,0.23912059377052985,['INHA'],0.9705683052108761,0,0,1
222,Oxidative Damage WP3941,0.7460520881967414,0.8162230671736375,0.23912059377052985,['CYCS'],0.9705683052108761,0,0,1
223,p38 MAPK Signaling Pathway WP400,0.7460520881967414,0.8162230671736375,0.23912059377052985,['DDIT3'],0.9705683052108761,0,0,1
224,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.7460520881967414,0.8162230671736375,0.23912059377052985,['BAX'],0.9705683052108761,0,0,1
225,EGF/EGFR signaling pathway WP437,0.7755465646196,0.7333969465648855,0.18642015559204975,"['NDUFA13', 'PRKCD', 'NEDD8']",0.9705683052108761,0,0,3
226,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.7851176124801658,0.780578034682081,0.1888388022938075,"['HSP90AA1', 'COL5A1', 'PIK3IP1', 'PDGFC', 'KIT', 'RPS6', 'VEGFB', 'FGF1']",0.9705683052108761,0,0,8
227,Small cell lung cancer WP4658,0.7860697353095506,0.6987755102040817,0.16820209144884216,"['CYCS', 'BAX']",0.9705683052108761,0,0,2
228,T-cell receptor (TCR) signaling pathway WP69,0.7860697353095506,0.6987755102040817,0.16820209144884216,"['TGFB1', 'PRKCD']",0.9705683052108761,0,0,2
229,G Protein Signaling Pathways WP35,0.7860697353095506,0.6987755102040817,0.16820209144884216,"['PRKCD', 'PRKD1']",0.9705683052108761,0,0,2
230,Melanoma WP4685,0.7860697353095506,0.6987755102040817,0.16820209144884216,"['KIT', 'BAX']",0.9705683052108761,0,0,2
231,Nuclear Receptors Meta-Pathway WP2882,0.7897972038354941,0.7837148372862659,0.18494029882489227,"['PSMC5', 'HSP90AA1', 'TGFB1', 'GSTP1', 'AIP', 'BAX', 'SLC39A7', 'CYP3A5', 'FTL']",0.9705683052108761,0,0,9
232,Breast cancer pathway WP4262,0.8196186618638126,0.666204024982651,0.13251870205627042,"['KIT', 'BAX', 'FGF1']",0.9705683052108761,0,0,3
233,Integrated breast cancer pathway WP1984,0.8196186618638126,0.666204024982651,0.13251870205627042,"['ODC1', 'BAX', 'FAU']",0.9705683052108761,0,0,3
234,3q29 copy number variation syndrome WP4906,0.8198282329073548,0.6116920152091255,0.12151900043916108,['TGFB1'],0.9705683052108761,0,0,1
235,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8198282329073548,0.6116920152091255,0.12151900043916108,['RPS6'],0.9705683052108761,0,0,1
236,Tumor suppressor activity of SMARCB1 WP4204,0.8198282329073548,0.6116920152091255,0.12151900043916108,['H3F3B'],0.9705683052108761,0,0,1
237,Unfolded protein response WP4925,0.8198282329073548,0.6116920152091255,0.12151900043916108,['DDIT3'],0.9705683052108761,0,0,1
238,White fat cell differentiation WP4149,0.8198282329073548,0.6116920152091255,0.12151900043916108,['DDIT3'],0.9705683052108761,0,0,1
239,Zinc homeostasis WP3529,0.8198282329073548,0.6116920152091255,0.12151900043916108,['SLC39A7'],0.9705683052108761,0,0,1
240,DNA Mismatch Repair WP531,0.8198282329073548,0.6116920152091255,0.12151900043916108,['POLE4'],0.9705683052108761,0,0,1
241,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.8198282329073548,0.6116920152091255,0.12151900043916108,['TGFB1'],0.9705683052108761,0,0,1
242,miRNA targets in ECM and membrane receptors WP2911,0.8198282329073548,0.6116920152091255,0.12151900043916108,['COL5A1'],0.9705683052108761,0,0,1
243,Regulation of Microtubule Cytoskeleton WP2038,0.8198282329073548,0.6116920152091255,0.12151900043916108,['PARD6A'],0.9705683052108761,0,0,1
244,Regulation of toll-like receptor signaling pathway WP1449,0.8198282329073548,0.6116920152091255,0.12151900043916108,['PELI3'],0.9705683052108761,0,0,1
245,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.8350295835415612,0.6109523809523809,0.11014745945089653,"['BEX3', 'RNF7']",0.9705683052108761,0,0,2
246,DNA damage response (only ATM dependent) WP710,0.8350295835415612,0.6109523809523809,0.11014745945089653,"['TGFB1', 'BAX']",0.9705683052108761,0,0,2
247,Ebola Virus Pathway on Host WP4217,0.8350295835415612,0.6109523809523809,0.11014745945089653,"['VPS4A', 'HLA-B']",0.9705683052108761,0,0,2
248,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.8350295835415612,0.6109523809523809,0.11014745945089653,"['PSMC5', 'STUB1']",0.9705683052108761,0,0,2
249,Pathways Regulating Hippo Signaling WP4540,0.8350295835415612,0.6109523809523809,0.11014745945089653,"['PRKCD', 'KIT']",0.9705683052108761,0,0,2
250,Adipogenesis WP236,0.8561010890553233,0.6102099236641222,0.09480637239567112,"['WWTR1', 'TGFB1', 'DDIT3']",0.9705683052108761,0,0,3
251,Circadian rhythm related genes WP3594,0.8561010890553233,0.6102099236641222,0.09480637239567112,"['CRH', 'RPS27A', 'HCRTR2']",0.9705683052108761,0,0,3
252,Vitamin D Receptor Pathway WP2877,0.8561010890553233,0.6102099236641222,0.09480637239567112,"['SFRP1', 'TGFB1', 'CYP3A5']",0.9705683052108761,0,0,3
253,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.8721998958989631,0.48897338403041823,0.06686057901347597,['TMSB4X'],0.9705683052108761,0,0,1
254,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.8721998958989631,0.48897338403041823,0.06686057901347597,['TGFB1'],0.9705683052108761,0,0,1
255,TGF-beta Receptor Signaling WP560,0.8721998958989631,0.48897338403041823,0.06686057901347597,['TGFB1'],0.9705683052108761,0,0,1
256,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.8721998958989631,0.48897338403041823,0.06686057901347597,['TGFB1'],0.9705683052108761,0,0,1
257,Thermogenesis WP4321,0.8721998958989631,0.48897338403041823,0.06686057901347597,['RPS6'],0.9705683052108761,0,0,1
258,Chemokine signaling pathway WP3929,0.8721998958989631,0.48897338403041823,0.06686057901347597,['PRKCD'],0.9705683052108761,0,0,1
259,Folate Metabolism WP176,0.8721998958989631,0.48897338403041823,0.06686057901347597,['GPX4'],0.9705683052108761,0,0,1
260,Imatinib and Chronic Myeloid Leukemia WP3640,0.8721998958989631,0.48897338403041823,0.06686057901347597,['KIT'],0.9705683052108761,0,0,1
261,MET in type 1 papillary renal cell carcinoma WP4205,0.8721998958989631,0.48897338403041823,0.06686057901347597,['RPL11'],0.9705683052108761,0,0,1
262,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.8721998958989631,0.48897338403041823,0.06686057901347597,['TGFB1'],0.9705683052108761,0,0,1
263,Nucleotide Excision Repair WP4753,0.8721998958989631,0.48897338403041823,0.06686057901347597,['POLE4'],0.9705683052108761,0,0,1
264,Peptide GPCRs WP24,0.8721998958989631,0.48897338403041823,0.06686057901347597,['HCRTR2'],0.9705683052108761,0,0,1
265,Phosphodiesterases in neuronal function WP4222,0.8721998958989631,0.48897338403041823,0.06686057901347597,['PDE3A'],0.9705683052108761,0,0,1
266,Prader-Willi and Angelman Syndrome WP3998,0.8721998958989631,0.48897338403041823,0.06686057901347597,['GABRD'],0.9705683052108761,0,0,1
267,Senescence and Autophagy in Cancer WP615,0.899374248063451,0.5731638735800247,0.0607874892164632,"['GABARAPL1', 'TGFB1', 'MAP1LC3A', 'GABARAP']",0.978811409621653,0,0,4
268,Cell cycle WP179,0.9037594115443701,0.488,0.049381740741319846,"['TGFB1', 'ANAPC11']",0.978811409621653,0,0,2
269,Oncostatin M Signaling Pathway WP2374,0.9037594115443701,0.488,0.049381740741319846,"['PRKCD', 'RPS6']",0.978811409621653,0,0,2
270,Regulation of Actin Cytoskeleton WP51,0.9037594115443701,0.488,0.049381740741319846,"['TMSB4X', 'FGF1']",0.978811409621653,0,0,2
271,PI3K-Akt signaling pathway WP4172,0.9069157265062822,0.6079654510556622,0.059401718989625756,"['HSP90AA1', 'PDGFC', 'KIT', 'RPS6', 'VEGFB', 'FGF1']",0.978811409621653,0,0,6
272,DNA IR-damage and cellular response via ATR WP4016,0.90936870826336,0.4071609632446134,0.038682183745822635,['FANCI'],0.978811409621653,0,0,1
273,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.90936870826336,0.4071609632446134,0.038682183745822635,['TGFB1'],0.978811409621653,0,0,1
274,Glucocorticoid Receptor Pathway WP2880,0.90936870826336,0.4071609632446134,0.038682183745822635,['HSP90AA1'],0.978811409621653,0,0,1
275,Photodynamic therapy-induced unfolded protein response WP3613,0.90936870826336,0.4071609632446134,0.038682183745822635,['DDIT3'],0.978811409621653,0,0,1
276,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9270707504558763,0.4432900432900433,0.03356831334833552,"['RPS6', 'PRKCD']",0.9892128701464026,0,0,2
277,Development of ureteric collection system WP5053,0.935741904192543,0.34872351982618144,0.02316067619337481,['GDF11'],0.9892128701464026,0,0,1
278,Fragile X Syndrome  WP4549,0.935741904192543,0.34872351982618144,0.02316067619337481,['GABRD'],0.9892128701464026,0,0,1
279,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.935741904192543,0.34872351982618144,0.02316067619337481,['TGFB1'],0.9892128701464026,0,0,1
280,Retinoblastoma gene in cancer WP2446,0.935741904192543,0.34872351982618144,0.02316067619337481,['H2AFZ'],0.9892128701464026,0,0,1
281,Wnt signaling WP428,0.95445081195629,0.3048954372623574,0.014213972200506412,['SFRP1'],0.9918762361473761,0,0,1
282,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.95445081195629,0.3048954372623574,0.014213972200506412,['SFRP1'],0.9918762361473761,0,0,1
283,Insulin Signaling WP481,0.9586528432516107,0.37450549450549453,0.01581396950239383,"['PRKCD', 'PFKM']",0.9918762361473761,0,0,2
284,"GPCRs, Class A Rhodopsin-like WP455",0.9670851763518187,0.40489821882951654,0.013551418763275492,"['P2RY14', 'MCHR1', 'HCRTR2']",0.9918762361473761,0,0,3
285,ESC Pluripotency Pathways WP3931,0.9677197303729166,0.27080692860160543,0.008885925020534133,['FGF1'],0.9918762361473761,0,0,1
286,Glioblastoma signaling pathways WP2261,0.9677197303729166,0.27080692860160543,0.008885925020534133,['PRKCD'],0.9918762361473761,0,0,1
287,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9677197303729166,0.27080692860160543,0.008885925020534133,['SFRP1'],0.9918762361473761,0,0,1
288,Head and Neck Squamous Cell Carcinoma WP4674,0.9771283051298727,0.2435361216730038,0.005634770729390477,['RPS6'],0.9918762361473761,0,0,1
289,Hippo-Merlin Signaling Dysregulation WP4541,0.9771283051298727,0.2435361216730038,0.005634770729390477,['KIT'],0.9918762361473761,0,0,1
290,Focal Adhesion WP306,0.9827955070924494,0.30357142857142855,0.005268242286082758,"['PDGFC', 'VEGFB']",0.9918762361473761,0,0,2
291,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9885253029171485,0.20262991128010138,0.0023385597923634245,['SST'],0.9918762361473761,0,0,1
292,Ciliopathies WP4803,0.9885253029171485,0.20262991128010138,0.0023385597923634245,['CCDC65'],0.9918762361473761,0,0,1
293,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9885253029171485,0.20262991128010138,0.0023385597923634245,['TGFB1'],0.9918762361473761,0,0,1
294,Endochondral Ossification WP474,0.9885253029171485,0.20262991128010138,0.0023385597923634245,['TGFB1'],0.9918762361473761,0,0,1
295,Ras signaling WP4223,0.9885253029171485,0.20262991128010138,0.0023385597923634245,['KIT'],0.9918762361473761,0,0,1
296,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9979609947569816,0.14247371952583315,0.0002908012345808826,['TM7SF2'],0.9979609947569816,0,0,1
